Events

Videos

Podcasts

Articles

Gynecologic Oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Heather Dalton, MD, gynecologic oncologist, Arizona Oncology, discusses toxicities in the frontline treatment of patients with ovarian cancer.
 

Dr. Dalton on Toxicities in the Frontline Treatment of Ovarian Cancer

Managing Ovarian Cancer Patients in the Future

Therapy Selection in BRCA-Mutated Ovarian Cancer

Sequencing Therapies in Ovarian Cancer

PARP Inhibitor Selection in Ovarian Cancer

Additional Considerations: PARPs for EOC in Practice

PARP Inhibitors in Recurrent Ovarian Cancer

Secondary Debulking in Recurrent Ovarian Cancer

Bevacizumab in Recurrent Ovarian Cancer

Approaching Recurrent Ovarian Cancer

Biomarkers and Molecular Testing in Ovarian Cancer

I-O Therapy in Advanced Ovarian Cancer

Maintenance Therapy in Ovarian Cancer: PARP Inhibitors

Bevacizumab in the Neoadjuvant Setting of EOC

Incorporating Bevacizumab into First-Line Practice for EOC

Upfront Bevacizumab in Advanced Ovarian Cancer

HIPEC in Advanced Ovarian Cancer

Adopting Neoadjuvant Therapy into Ovarian Cancer

Niraparib (Zejula) met the primary endpoint of overall response as a fourth-line or later treatment in patients with ovarian cancer, regardless of BRCA status, according to top-line results from the QUADRA study.

Niraparib Active in Heavily Pretreated Ovarian Cancer, Regardless of BRCA Status

Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses surgical options for the treatment of patients with newly-diagnosed ovarian cancer.

Dr. Wingo on the Evolution of Surgery in Patients With Ovarian Cancer

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Ovarian Cancer

GSK-22-OSD1278 - /clinical/ovarian-cancer

Ovarian Cancer | Specialty